Preclinical R&D Lead

Your new company Hays Life Sciences have partnered with an innovative synthetic biology company dedicated to revolutionising drug delivery.
Their cutting-edge technology utilises novel approaches to deliver therapeutic payloads with ultra-high precision.
This breakthrough approach aims to transform how biological medicines are administered, offering targeted and efficient solutions.